These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 10212757

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. In-vitro activity of quinupristin/dalfopristin compared with other widely used antibiotics against strains isolated from patients with endocarditis.
    Mouton JW, Endtz HP, den Hollander JG, van den Braak N, Verbrugh HA.
    J Antimicrob Chemother; 1997 May; 39 Suppl A():75-80. PubMed ID: 9511068
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Vancomycin-resistant enterococci: in vitro activity of quinupristin / dalfoprostin (RP 59500)].
    Betriu C, Valverde JF, Culebras E, Gómez M, Sánchez A, Palau ML, Picazo JJ.
    Enferm Infecc Microbiol Clin; 1999 May; 17(7):335-9. PubMed ID: 10535185
    [Abstract] [Full Text] [Related]

  • 28. In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria.
    Malathum K, Coque TM, Singh KV, Murray BE.
    Antimicrob Agents Chemother; 1999 Apr; 43(4):930-6. PubMed ID: 10103202
    [Abstract] [Full Text] [Related]

  • 29. In vitro activity and post-antibiotic effect of quinupristin/dalfopristin (Synercid).
    Ling TK, Fung KS, Cheng AF.
    Chemotherapy; 2001 Apr; 47(4):243-9. PubMed ID: 11399860
    [Abstract] [Full Text] [Related]

  • 30. Activity of quinupristin/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes.
    Baudoux P, Lemaire S, Denis O, Tulkens PM, Van Bambeke F, Glupczynski Y.
    J Antimicrob Chemother; 2010 Jun; 65(6):1228-36. PubMed ID: 20378672
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin-dalfopristin against Enterococcus faecium.
    Bozdogan B, Leclercq R.
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2720-5. PubMed ID: 10543753
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria].
    Igari J, Oguri T, Hiramatsu N, Akiyama K, Koyama T.
    Jpn J Antibiot; 2002 Feb; 55(1):1-21. PubMed ID: 11977919
    [Abstract] [Full Text] [Related]

  • 35. Antimicrobial susceptibilities of clinical isolates of vancomycin-resistant enterococci in Taiwan.
    Hsueh PR, Wu JJ, Lu JJ, Teng LJ, Luh KT.
    J Formos Med Assoc; 1999 Jan; 98(1):45-8. PubMed ID: 10063273
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparison of the in vitro activity of pristinamycin and quinupristin/dalfopristin against Streptococcus pneumoniae.
    Lozniewski A, Lion C, Mory F, Weber M.
    Pathol Biol (Paris); 2000 Jun; 48(5):463-6. PubMed ID: 10949841
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. In vitro activities of a new ketolide, ABT-773, against multidrug-resistant gram-positive cocci.
    Singh KV, Malathum K, Murray BE.
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3640-3. PubMed ID: 11709359
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.